Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

Dong Zhao(Beijing University of Chemical Technology), Kangsheng Gu(Anhui Medical University), Xiaofei Cheng(Anqing City Hospital), Huaidong Cheng(Third Affiliated Hospital of Southern Medical University), Xiaoyang Xia, Man Li(Second Affiliated Hospital of Jilin University), Huan Chen(Beth Israel Deaconess Medical Center), Hui Liang(Chinese Academy of Agricultural Sciences), Kehai Feng, Xuhong Min(Xi'an Chest Hospital), Hua Xie, Minghong Bi(Bengbu Medical College), Zhiqiang Hu(Zhejiang University), Yanbei Zhang(Anhui Medical University), Ling Xu(Shanghai University of Traditional Chinese Medicine), Shuhong Wang, Qisheng Cao(Anshan Hospital), Fan Wang(Anhui Medical University), Jinhua Zhou(Yunnan Academy of Agricultural Sciences), Rui Wang(Separation Systems (United States)), Xiaosi Chen
Frontiers in Immunology
March 7, 2025
Cited by 2


Related Papers